CNS+ is a professional medical education and clinical reference app for neurosurgeons, providing access to CME tracking and surgical guidelines on iOS and Android.
The App DNA
What makes this app unique?
The app removes the friction of managing mandatory professional certification and clinical reference material by centralizing CNS-provided resources into a single mobile account.
For Doctors, nurses, and medical students specializing in neurology who require access to professional guidelines and CME tracking.
What does it look like?
Key features
Links the app to a user's CNS.org account to sync educational progress and CME credits.
Digital reference tool for surgical procedures and clinical decision support.
Provides mobile access to My Education and My CME modules for professional certification.
How much does it cost?
The app functions as a free utility for existing members, gating all content behind a required CNS.org account login.
Velocity
Dormant developmentopaqueShow more...
CNS+ has reached a state of inactivity, with no new feature builds or updates released in the last 359 days. The development momentum is non-existent, as the last recorded update was a minor maintenance release. Given the lack of activity over the past year, the app is classified as a zombie project.
Who built it?
Congress of Neurological Surgeons
3 apps tracked · Medical
User Sentiment
What do users think recently?
Recent user voice shows a mixed sentiment. Users appreciate neurosurgeons find the organized resource structure helpful for quick reference during their daily clinical practice.
How are ratings & reviews evolving?
What users say, by theme
- Neurosurgeons find the organized resource structure helpful for quick reference during their daily clinical practice
- Learning modules and question banks fail to open or function after purchase, blocking access to content
4 of 4 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for CNS+
How's the Medical market?
CNS+ functions as a closed-loop professional tool for the Congress of Neurological Surgeons, with a 5-star rating on iOS but a 3-star rating on Android across a small review sample. The disparity in user experience suggests that the latest version has not achieved parity in stability across platforms.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for CNS+
Where is it heading?
The outlook for CNS+ is declining due to a lack of active feature investment and unresolved functional failures. The app's reliance on member-only access provides a temporary buffer against competition, but the failure to deliver on core educational promises will eventually force users to seek alternative CME tracking solutions.
- The 11-month development gap indicates a maintenance-only posture, which leaves the app vulnerable to functional decay as OS requirements evolve.
- Persistent reports of inaccessible learning modules in the latest version erode professional trust, which will likely lead to increased churn in CME tracking usage.
The SWOT
- Centralized CME tracking creates high professional switching costs
- Interactive clinical decision support tools could increase daily session frequency
Next best moves
Audit and rebuild the learning module loading logic because users report purchased question banks remain inaccessible → restore user trust
+ 1 more prioritized moveThe counter-intuitive read
The app's lack of updates is a deliberate strategy to maintain a stable…
Read the full takeBottom line
CNS+ provides essential professional utility, but the failure of core learning modules creates a significant trust deficit. Addressing these functional regressions is necessary to maintain the app's role as a reliable certification tool for the neurosurgical community.
Unlock 1 critical friction, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] Play Store listing
Report last updated